Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition:   Myopia Interventions:   Device: CP1;   Drug: 0.01% atropine Sponsors:   Kubota Vision Inc.;   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition:   Myopia Interventions:   Drug: 0.01% atropine;   Other: 0.9% sodium chloride Sponsor:   He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions:   Myopia;   Juvenile Myopia;   Myopia Progression Interventions:   Device: Single vision, impact-resistant spectacle lenses; Test Arm;   Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor:   SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition:   Myopia Interventions:   Device: CP1;   Drug: 0.01% atropine Sponsors:   Kubota Vision Inc.;   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition:   Myopia Interventions:   Drug: 0.01% atropine;   Other: 0.9% sodium chloride Sponsor:   He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions:   Myopia;   Juvenile Myopia;   Myopia Progression Interventions:   Device: Single vision, impact-resistant spectacle lenses; Test Arm;   Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor:   SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition:   Myopia Interventions:   Device: CP1;   Drug: 0.01% atropine Sponsors:   Kubota Vision Inc.;   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition:   Myopia Interventions:   Drug: 0.01% atropine;   Other: 0.9% sodium chloride Sponsor:   He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions:   Myopia;   Juvenile Myopia;   Myopia Progression Interventions:   Device: Single vision, impact-resistant spectacle lenses; Test Arm;   Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor:   SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition:   Myopia Interventions:   Device: CP1;   Drug: 0.01% atropine Sponsors:   Kubota Vision Inc.;   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition:   Myopia Interventions:   Drug: 0.01% atropine;   Other: 0.9% sodium chloride Sponsor:   He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions:   Myopia;   Juvenile Myopia;   Myopia Progression Interventions:   Device: Single vision, impact-resistant spectacle lenses; Test Arm;   Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor:   SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition:   Myopia Interventions:   Device: CP1;   Drug: 0.01% atropine Sponsors:   Kubota Vision Inc.;   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition:   Myopia Interventions:   Drug: 0.01% atropine;   Other: 0.9% sodium chloride Sponsor:   He Eye Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions:   Myopia;   Juvenile Myopia;   Myopia Progression Interventions:   Device: Single vision, impact-resistant spectacle lenses; Test Arm;   Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor:   SightGlass Vision, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials